VitaNova Life Sciences annual operating margin
2022
2023
2024
2025
2026
VitaNova Life Sciences's operating margin was 0.12% for fiscal 2026.
View full VitaNova Life Sciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-30 | 0.12% | −45.27 pp |
| 2025 | 2025-04-30 | 45.39% | +9.36 pp |
| 2024 | 2024-04-30 | 36.03% | +99.79 pp |
| 2023 | 2023-04-30 | −63.76% | −52.62 pp |
| 2022 | 2022-04-30 | −11.14% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-04-30 | −6.15% | −61.56 pp |
| Q3 2026 | 2026-01-31 | 6.59% | −28.73 pp |
| Q2 2026 | 2025-10-31 | 23.22% | +1.79 pp |
| Q1 2026 | 2025-07-31 | −31.22% | +10.64 pp |
| Q4 2025 | 2025-04-30 | 55.41% | +12.68 pp |
| Q3 2025 | 2025-01-31 | 35.31% | +12.52 pp |
| Q2 2025 | 2024-10-31 | 21.43% | +7.20 pp |
| Q1 2025 | 2024-07-31 | −41.87% | +24.78 pp |
| Q4 2024 | 2024-04-30 | 42.73% | +30.77 pp |
| Q3 2024 | 2024-01-31 | 22.79% | — |
| Q1 2023 | 2022-07-31 | 14.23% | — |
| Q2 2022 | 2021-10-31 | −66.65% | — |
| Q2 2018 | 2017-10-31 | 11.96% | — |
Across the available reported history, VitaNova Life Sciences's operating margin decreased from 45.39% to 0.12%, a change of −45.27 percentage points. The latest reported quarter, Q4 2026, shows −6.15%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VitaNova Life Sciences filings at SEC.gov ↗